You're right. This is my own post on NEU. I spend most of my time doing actual academic research on epigenetic dysregulation in Rett Syndrome, Prader-Willi and Angelman's.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren initiates development of NNZ-2591 to treat HIE
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.91%
!
$17.51

Ann: Neuren initiates development of NNZ-2591 to treat HIE, page-85
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.51 |
Change
0.495(2.91%) |
Mkt cap ! $2.205B |
Open | High | Low | Value | Volume |
$17.48 | $18.44 | $17.40 | $11.22M | 626.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 19 | $17.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.51 | 27 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 279 | 17.490 |
4 | 184 | 17.480 |
8 | 698 | 17.470 |
6 | 585 | 17.460 |
8 | 1229 | 17.450 |
Price($) | Vol. | No. |
---|---|---|
17.500 | 80 | 4 |
17.510 | 63 | 3 |
17.520 | 332 | 4 |
17.530 | 405 | 5 |
17.540 | 1058 | 5 |
Last trade - 13.55pm 07/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |